Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?

Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients

(2012) Lorenzo Leggio et al.   CNS & Neurological Disorders-Drug Targets

Neuropharmacology of addiction and how it informs treatment

(2010) Anne Lingford-Hughes et al.   BRITISH MEDICAL BULLETIN

Antagonist—agonist combinations as therapies for heroin addiction: back to the future?

(2010) David J Nutt   JOURNAL OF PSYCHOPHARMACOLOGY

The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study

(2009) Teresa R. Franklin et al.   DRUG AND ALCOHOL DEPENDENCE

The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review

(2009) Cleo L. Crunelle et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist Naltrexone in the Treatment of Pathological Gambling Urges

(2009) Jon E. Grant et al.   JOURNAL OF CLINICAL PSYCHIATRY

Targeted Naltrexone for Problem Drinkers

(2009) Henry R. Kranzler et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Acamprosate: Recent Findings and Future Research Directions

(2008) Karl Mann et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH